tiprankstipranks
Trending News
More News >
CUC Inc. (JP:9158)
:9158
Japanese Market

CUC Inc. (9158) AI Stock Analysis

Compare
0 Followers

Top Page

JP:9158

CUC Inc.

(9158)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 5.2)
Rating:68Neutral
Price Target:
¥1,089.00
▲(28.42% Upside)
Action:ReiteratedDate:02/04/26
The score is driven primarily by strong financial performance in growth and margins, offset by negative free cash flow and only moderate cash conversion. Technically, the stock shows mixed signals with weak longer-term trend and negative MACD despite neutral RSI and some near-term support. Valuation appears reasonable with a mid-teens P/E, but no dividend data is available to add support.
Positive Factors
Revenue Growth
Revenue growth of ~42.5% reflects strong and durable demand for CUC's care services and expanding market penetration. Sustained top-line expansion increases scale, improves bargaining power with suppliers, and creates capacity to reinvest in facilities and services, supporting multi‑month strategic growth initiatives.
Margin Profile
High gross and solid EBIT/EBITDA margins indicate efficient operations and pricing power within the medical care facilities industry. Sustainable margins enhance earnings resilience through cycles, provide internal funding for maintenance capex and modest expansion, and underpin long‑term profitability even as the company scales.
ROE & Capital Mix
A 10.6% ROE and a 34.8% equity ratio show the company generates reasonable returns on shareholder capital while maintaining a balanced capital mix. This stability supports access to financing, credibility with lenders, and the ability to fund strategic investments without excessive dilution over the medium term.
Negative Factors
Negative Free Cash Flow
Persistent negative free cash flow (-3.0B) is a structural weakness: it constrains the company's ability to self‑fund capex, reduce debt, or return capital. Over several months this may necessitate external financing or slower reinvestment, increasing financial risk if operating cash generation doesn't improve.
Weak Cash Conversion
Operating cash flow covers only ~80% of net income, indicating earnings are not fully translating to cash. This moderate conversion raises liquidity sensitivity to working capital swings, limits internal funding for growth and debt service, and exacerbates the impact of any revenue slowdown on available cash.
Elevated Leverage
A debt-to-equity ratio of 1.47 and 43.5B in total debt create meaningful leverage. Combined with negative FCF and modest cash conversion, this elevates refinancing and interest-rate risk, narrows strategic flexibility, and increases the potential for strain on margins and cash flow if growth moderates.

CUC Inc. (9158) vs. iShares MSCI Japan ETF (EWJ)

CUC Inc. Business Overview & Revenue Model

Company DescriptionCUC Inc. offers healthcare services in Japan, Asia and internationally. It provides hospital care, dialysis care, visiting nurses, and home hospices services, as well as management support services for healthcare institutions; and healthcare consulting services. The company was founded in 2014 and is based in Minato-Ku, Japan. CUC Inc. operates as a subsidiary of M3 Inc.
How the Company Makes MoneyCUC Inc. generates revenue through a multi-faceted model that includes subscription-based services, licensing fees for software products, and consulting services. The primary revenue stream comes from recurring subscriptions to its cloud services, which provide businesses with scalable IT infrastructure and support. Additionally, CUC Inc. earns income through the sale of proprietary software licenses, allowing companies to utilize its tools for data management and analytics. Strategic partnerships with other technology firms and service providers enhance its offerings and enable cross-selling opportunities, further contributing to its financial performance.

CUC Inc. Financial Statement Overview

Summary
Strong revenue growth (~42.5% YoY) and improving margins support profitability, but negative free cash flow (-3.0B) and only moderate cash conversion (operating cash flow to net income at 0.80) materially weaken the financial picture. Balance sheet leverage is moderate (debt-to-equity 1.47) with a solid equity ratio (34.8%), though total debt remains a key risk.
Income Statement
85
Very Positive
CUC Inc. has demonstrated strong revenue growth, with a significant increase from 33.0 billion to 47.0 billion over the last year, representing a growth rate of approximately 42.5%. The gross profit margin has improved to 42.3%, indicating efficient cost management. The net profit margin stands at 6.7%, showing profitability, though there's room for improvement. EBIT and EBITDA margins are 10.1% and 19.2% respectively, reflecting solid operational efficiency.
Balance Sheet
75
Positive
The company's debt-to-equity ratio is 1.47, indicating a moderate level of leverage. The return on equity (ROE) is 10.6%, suggesting decent profitability relative to shareholder equity. The equity ratio is 34.8%, showing a stable capital structure with a good proportion of assets financed by equity. However, the high level of total debt at 43.5 billion poses a risk if not managed carefully.
Cash Flow
60
Neutral
CUC Inc. has faced challenges with free cash flow, which is negative at -3.0 billion, although it has improved from the previous year. The operating cash flow to net income ratio is 0.80, indicating that operating cash flow is not fully covering net income, which could be a concern. The free cash flow to net income ratio is negative, highlighting the need for better cash flow management.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue49.44B47.04B33.02B35.21B35.31B16.61B
Gross Profit22.92B19.89B15.92B13.78B14.25B7.55B
EBITDA8.10B9.04B6.23B4.95B4.79B2.46B
Net Income2.37B3.13B2.60B2.42B2.71B1.10B
Balance Sheet
Total Assets86.17B85.17B62.84B39.75B34.53B28.45B
Cash, Cash Equivalents and Short-Term Investments7.04B7.53B8.26B4.12B4.36B3.62B
Total Debt48.16B43.54B26.72B21.45B14.90B18.77B
Total Liabilities56.07B54.88B34.83B27.83B24.85B23.10B
Stockholders Equity29.54B29.68B27.32B11.70B9.46B4.73B
Cash Flow
Free Cash Flow0.00-3.04B-747.00M-3.23B5.77B1.64B
Operating Cash Flow0.002.50B4.16B2.36B6.62B2.12B
Investing Cash Flow0.004.45B-14.75B-6.68B-1.47B-2.42B
Financing Cash Flow0.00-7.60B14.37B3.97B-4.43B-591.00M

CUC Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price848.00
Price Trends
50DMA
894.42
Positive
100DMA
955.23
Negative
200DMA
1040.04
Negative
Market Momentum
MACD
17.47
Positive
RSI
47.05
Neutral
STOCH
48.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9158, the sentiment is Negative. The current price of 848 is below the 20-day moving average (MA) of 938.65, below the 50-day MA of 894.42, and below the 200-day MA of 1040.04, indicating a neutral trend. The MACD of 17.47 indicates Positive momentum. The RSI at 47.05 is Neutral, neither overbought nor oversold. The STOCH value of 48.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9158.

CUC Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥30.28B17.642.48%3.88%0.31%
72
Outperform
¥44.45B13.452.63%0.30%-31.28%
68
Neutral
¥26.76B14.9231.65%-51.36%
68
Neutral
¥94.27B21.602.47%1.86%1370.48%
62
Neutral
¥47.58B13.900.91%15.77%-50.57%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
48
Neutral
¥8.73B-2.8210.09%-340.83%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:9158
CUC Inc.
913.00
-517.00
-36.15%
JP:2374
Saint-Care Holding Corp.
1,211.00
493.58
68.80%
JP:6062
Charm Care Corporation
1,363.00
151.25
12.48%
JP:6197
Solasto Corp.
995.00
545.82
121.51%
JP:7071
Amvis Holdings.Inc.
484.00
-165.70
-25.50%
JP:9229
SUNWELS Co.,Ltd.
248.00
-393.83
-61.36%

CUC Inc. Corporate Events

CUC Inc. Grows Revenue but Profit and EPS Decline Sharply in Nine-Month Results
Feb 2, 2026

For the nine months ended December 31, 2025, CUC Inc. reported revenue of ¥40.17 billion, up 16.2% year-on-year, but saw a sharp decline in profitability, with operating profit down 30.5% to ¥3.18 billion and net income attributable to shareholders falling 48.3% to ¥1.43 billion, driving basic earnings per share down to ¥48.87. Despite growth in total assets and equity, the company maintained a zero-dividend policy for the current and forecast fiscal year and projected full-year revenue growth of 23.8% to ¥58.25 billion alongside only modest operating profit growth and declining net income, signaling pressure on margins and a cautious return profile for shareholders.

The most recent analyst rating on (JP:9158) stock is a Hold with a Yen906.00 price target. To see the full list of analyst forecasts on CUC Inc. stock, see the JP:9158 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 04, 2026